Caxton Associates (New York)’s Nucor NUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,258
Closed -$219K 552
2023
Q4
$219K Buy
+1,258
New +$199K 0.01% 420
2019
Q4
Sell
-13,416
Closed -$683K 509
2019
Q3
$683K Buy
+13,416
New +$700K 0.14% 85
2018
Q4
Sell
-94,253
Closed -$5.98M 424
2018
Q3
$5.98M Sell
94,253
-125,747
-57% -$8.05M 0.41% 61
2018
Q2
$13.8M Buy
220,000
+115,000
+110% +$7.34M 0.69% 23
2018
Q1
$6.41M Buy
+105,000
New +$6.95M 0.33% 62
2017
Q3
Sell
-6,400
Closed -$370K 586
2017
Q2
$370K Buy
+6,400
New +$375K 0.01% 417
2016
Q3
Sell
-503,700
Closed -$24.9M 227
2016
Q2
$24.9M Buy
503,700
+382,100
+314% +$18.6M 0.69% 32
2016
Q1
$5.75M Buy
+121,600
New +$4.95M 0.41% 37

Other funds holding NUE

Caxton Associates (New York)'s NUE Position: Q1 2024 in Review

Caxton Associates (New York) sold out of Nucor (NUE) in Q1 2024, closing a stake of 1,258 shares — an estimated $219K sold.

Caxton Associates (New York) first reported a position in NUE in Q1 2016 and held it in 8 quarters. The position peaked at $24.9M in Q2 2016. 1,295 funds tracked by Wall St. Rank hold NUE as of Q1 2024.

  • Caxton Associates (New York) reported no remaining Nucor position as of Q1 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 1,258 Nucor shares in Q1 2024, an estimated $219K.
  • Caxton Associates (New York) first reported a position in Nucor in Q1 2016 and held it in 8 quarters.
  • Caxton Associates (New York)'s Nucor position peaked at $24.9M in Q2 2016.
  • 1,295 funds tracked by Wall St. Rank held Nucor as of Q1 2024.

Based on Caxton Associates (New York)'s 13F filing for Q1 2024, filed 15 May 2024.